Explore

Rapid Read Rapid Read
ICIBM 2026 Conference Highlights Advances in Bioinformatics for Health and Disease

ICIBM 2026 Conference Highlights Advances in Bioinformatics for Health and Disease

The 14th International Conference on Intelligent Biology and Medicine (ICIBM 2026) is set to showcase significant advancements in bioinformatics and computational biology. The conference will focus on integrating multi-omics data for disease subtyping, prognosis, and treatment response. Topics include precision medicine, pharmacogenomics, and AI-driven analysis of genomics data. The event aims to address the challenges posed by the scale and complexity of biological data, emphasizing the need for new bioinformatics methods to translate data into biological discoveries and insights into human health and disease.
Trendline Trendline
Orano Med Reports Progress in Cancer Treatment Development and Business Expansion

Orano Med Reports Progress in Cancer Treatment Development and Business Expansion

Orano Med Reports Progress in Cancer Treatment Development and Business Expansion
Rapid Read Rapid Read
City University of Hong Kong Researchers Use Comparative Oncology to Advance Cancer Treatment

City University of Hong Kong Researchers Use Comparative Oncology to Advance Cancer Treatment

Researchers at the City University of Hong Kong (CityU HK) are employing comparative oncology to explore the similarities between cancer-causing viruses in cats and humans. This approach aims to enhance treatment options for both species. Julia Beatty, a chair professor of veterinary medicine and infectious diseases at CityU HK, highlights the potential of preventing virus-induced cancers through vaccination and treatment. The research has identified a hepatitis B virus-like infection in cats, which is linked to liver cancer, mirroring similar conditions in humans. This study emphasizes the importance of field research over laboratory studies, as it provides insights into naturally occurring infections in cats living in human environments.
Rapid Read Rapid Read
Viagra Shows Potential in Limiting Cancer Spread by Targeting Cholesterol

Viagra Shows Potential in Limiting Cancer Spread by Targeting Cholesterol

Recent research from the Weizmann Institute of Science in Tel Aviv suggests that Viagra, known scientifically as sildenafil, may help limit the spread of cancer by restricting cancer cells' access to cholesterol. Cholesterol is crucial for cancer cells to break away from primary tumors and invade other parts of the body. The study, published in the journal Cancer Research, indicates that sildenafil's effects are enhanced when used in conjunction with statins, which are medications that limit cholesterol production. The combination of these drugs could potentially prevent cancer cells from accessing existing cholesterol and producing new cholesterol, thereby enhancing the anti-metastatic effect. The research highlights the role of a patient's metabolic state and existing medications in shaping cancer progression.
Rapid Read Rapid Read
Traditional Chinese Medicine Shows Promise in Treating Neurodegenerative Disorders

Traditional Chinese Medicine Shows Promise in Treating Neurodegenerative Disorders

A recent review has explored the potential of Traditional Chinese Medicine (TCM) in treating neurodegenerative diseases (NDDs) such as Alzheimer's, Parkinson's, and Huntington's diseases. The study highlights cellular senescence as a key factor in the pathogenesis of these disorders, characterized by irreversible cell cycle arrest and the secretion of pro-inflammatory cytokines. TCM-derived compounds, including ginsenosides, ginkgo biloba extract, and curcumin, have shown promise in modulating cellular senescence and alleviating neurodegeneration. The review examines the molecular signaling pathways linking cellular senescence to NDDs and discusses the translational potential of these natural compounds for clinical application.
Trendline Trendline
Orano Med Reports Progress in Nuclear Medicine and Business Outlook

Orano Med Reports Progress in Nuclear Medicine and Business Outlook

Orano Med Reports Progress in Nuclear Medicine and Business Outlook
Trendline Trendline
Moderna's Norovirus Vaccine Trial Faces Setback, Extends into Fourth Season

Moderna's Norovirus Vaccine Trial Faces Setback, Extends into Fourth Season

Moderna's Norovirus Vaccine Trial Faces Setback, Extends into Fourth Season
Rapid Read Rapid Read
Dana-Farber Cancer Institute Seeks Computational Biologist to Enhance Cancer Research

Dana-Farber Cancer Institute Seeks Computational Biologist to Enhance Cancer Research

Dana-Farber Cancer Institute in Boston is hiring a Computational Biologist I to support its mission of advancing cancer research and patient care. The role involves data analysis and processing of biological data, focusing on high-throughput technologies and genomic databases. The position requires collaboration with scientific investigators and research staff to analyze data and disseminate scientific results. The institute emphasizes an inclusive and diverse environment, aiming to provide comprehensive care to patients of all backgrounds and promote public health among high-risk and underserved populations.
Trendline Trendline
Genome Mining Reveals Less Toxic, Potent Antifungal Polyenes in Mice

Genome Mining Reveals Less Toxic, Potent Antifungal Polyenes in Mice

Genome Mining Reveals Less Toxic, Potent Antifungal Polyenes in Mice
Rapid Read Rapid Read
Organoids and New Methodologies Transform Drug Discovery Landscape

Organoids and New Methodologies Transform Drug Discovery Landscape

The field of drug discovery is experiencing a significant transformation with the adoption of New Approach Methodologies (NAMs), including organoids, organs-on-chip, and engineered 3D tissues. These technologies are moving from proof-of-concept to everyday use in drug screening, discovery, and safety studies. The FDA Modernization Act 2.0 and other regulatory frameworks are accelerating the shift towards non-animal models. This research topic brings together leaders from academia, industry, and regulatory agencies to discuss the current state and future directions of NAMs in drug discovery.
Trendline Trendline
LLNL and UC Davis Collaborate to Innovate Food Systems and Human Health

LLNL and UC Davis Collaborate to Innovate Food Systems and Human Health

LLNL and UC Davis Collaborate to Innovate Food Systems and Human Health
Rapid Read Rapid Read
CORAL: A New Spatial Proteomics Processing Suite Launched by Mahmood Lab

CORAL: A New Spatial Proteomics Processing Suite Launched by Mahmood Lab

Mahmood Lab has launched CORAL, a new spatial proteomics processing suite designed to streamline the analysis of tissue slides. CORAL offers a comprehensive toolkit that simplifies the process from raw tissue slides to biological insights, focusing on cell types, spatial neighborhoods, and patient outcomes. The suite is Foundation Model-centric, utilizing pretrained models on extensive spatial proteomics datasets. CORAL supports multiplexed antibody imaging platforms like CODEX and PhenoCycler, with plans to expand to spatial transcriptomics. The suite automates the entire workflow, making it accessible for researchers to conduct complex analyses without extensive computational expertise.